This information is for residents of the United Arab Emirates.

Spikevax XFG 50 microgram dispersible for injection in a pre-filled syringe

Spikevax® XFG is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet

View

Summary of Product Characteristics

Spikevax LP.8.1 50 microgram dispersible for injection in a pre-filled syringe

Spikevax® LP.8.1 is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Spikevax JN.1 50 microgram dispersible for injection in a pre-filled syringe

Spikevax® JN.1 is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics